<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_INSA-UPS_France_Design skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:INSA-UPS France/Design</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container" style="position:relative; "><DIV class="site-header__title">
    Croc'n Cholera <SPAN style="font-size:12pt;">iGEM UPS-INSA Toulouse 2017</SPAN></DIV><NAV class="site-menu" style="text-align: center;"><DIV class="site-menu__item"><DIV class="cat_name">Team </DIV><UL class="subnav" style="width:150%;"><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Team">Members</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Supports">Supports</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Attributions">Attributions</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Collaborations">Collaborations</A></LI></UL></DIV><DIV class="site-menu__item"><DIV class="cat_name">Strategy </DIV><UL class="subnav"><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Description">Description</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Design">Design</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Parts">Parts</A></LI></UL></DIV><DIV class="site-menu__item"><DIV class="cat_name">Model </DIV><UL class="subnav"><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Model">Overview</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Model/Simulation">Simulation</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Model/Analysis">Analysis</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Model/Interface">Interface</A></LI></UL></DIV><DIV class="site-menu__item"><DIV class="cat_name">Realisations </DIV><UL class="subnav"><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Experiments">Overview</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Notebook">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Experiments/Clonings">Clonings</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Results">Results</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Contribution">Contribution</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Protocols">Protocols</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Safety">Safety</A></LI></UL></DIV><DIV class="site-menu__item"><DIV class="cat_name">Human Practices</DIV><UL class="subnav"><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Human_Practices">Overview</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/HP/Silver">Silver</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/HP/Gold_Integrated">Gold</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Engagement">Public Engagement</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Microbioworld">Microbioworld</A></LI></UL></DIV><DIV class="site-menu__item"><DIV class="cat_name">Application </DIV><UL class="subnav"><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Applied_Design">Applied Design</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Entrepreneurship/Testimonies">Testimonies</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Entrepreneurship">Entrepreneurship</A></LI><LI><A href="https://2017.igem.org/Team:INSA-UPS_France/Entrepreneurship/Device">Device Conception</A></LI></UL></DIV></NAV></DIV><DIV class="main_content"><DIV class="middle_container"><DIV class="section_container"><SECTION style="margin-top:200px;"><H1 style="text-align: left;margin-top:-110px;font-size:5vw;letter-spacing: 1vw;">Design</H1><P style="margin-top: 50px;">
        We created a synthetic consortium and demonstrated the power of such approach to fight against cholera disease. Our synthetic consortium involves three microorganism: i) an engineered <I>E. coli</I> to mimic<I> V. cholerae</I> ii) an engineered V. harveyi to sense the presence of the engineered <I>E. coli</I> and in repsonse to produce diacetyl iii) a yeast <I>P. pastoris</I> engineered to detect diacetyl and in response to produce antibacterial peptides (AMPs) in order to trigger lysis of<I> Vibrio </I> species. Here is presented a closer view of the molecular details for each micro-organism as well as an overview of our experimental plan.

      </P></SECTION><SECTION style="background: none;"><H1 style="text-align:left;">Overview</H1></SECTION><H1 style="font-family: 'Quicksand', sans-serif;font-size:34pt;text-align: left;margin:20px 10%;">Modules &amp; Parts</H1><DIV class="right_container"><SECTION class="modules_design" style="border:solid 5px #ae3d3d;margin-top:0px;margin-bottom: 20px;"><H2 style="color:#ae3d3d;"><I>Escherichia coli</I></H2><P>
        For safety reasons, the bacteria gram negative <I>E. coli</I> was chosen to mimic <I> V. cholerae</I>. <I>E. coli</I> is an easy organism to deal with, especially as it is well documented, easy to transform with exogenous DNA and easy to culture. The strain K-12 MG1655 was transformed with a plasmid allowing expression of the protein CqsA from<I> V. cholerae</I>, the enzyme responsible for the synthesis of CAI-1. However, as a proof of concept, we also transformed our <I>E. coli</I> strain with the gene coding for the CqsA of V. harveyi, a non-pathogen strain, producing the molecule C8-CAI-1 (an analogue of the<I> V. cholerae</I> CAI-1)<SUP><A href="https://www.ncbi.nlm.nih.gov/pubmed/21219472/" target="_blank">1</A>,<A href="https://www.ncbi.nlm.nih.gov/pubmed/15466044/" target="_blank">2</A></SUP>. C8-CAI1 is a carbohydrate chain based displaying an hydroxyl group on carbon 3 and ketone function on carbon 4. The CqsA synthetase from V. harveyi produce C8-CAI-1 from endogenous <I>E. coli</I> (S)-adenosylmethionine (SAM) and octanoyl-coenzyme. <I> cqsA </I> from both <I>V. harveyi</I> and <I> V. cholerae</I> were placed under the pLac promoter and we used plasmid pSB1C3 to maintain compatibility with the iGEM registry.
      </P></SECTION><SECTION class="modules_design" style="border:solid 5px #468789;margin-top:0px;margin-bottom: 20px;"><H2 style="color:#468789;"><I>V. harveyi</I></H2><P><I>V. harveyi</I> is a gram negative bacteria, well studied for its quorum sensing system. This bacteria displays its own pathway for the detection of C8-CAI-1. The gene <I>cqsS</I> encodes for the sensor C8-CAI-1 and a single point mutation in its sequence allows <I>V. harveyi</I> to detect both C8-CAI-1 and CAI-1 from <I> V. cholerae</I>. To avoid auto-activation of <I>V. harveyi</I>, we used the JMH626 strain, in which the <I> cqsA </I> gene, coding the enzyme involved in the production C8-CAI-1, has been deleted. Furthermore, additional genes <I>luxS</I> and <I>luxS</I> coding for key enzymes involved in the expression of other quorum sensing molecules have been deleted. All these mutations make the strain JMH626 specific for detecting non-endogenous C8-CAI-1. <I>V. harveyi</I> is also able to regulate the activation of genes under the control of the promoter pQRR4, in a C8-CAI-1 concentration dependent manner <SUP><A href="https://www.ncbi.nlm.nih.gov/pubmed/21219472/" target="_blank">1</A></SUP>. At high C8-CAI-1 concentration, the promoter is inactivated. Thus we added the inverter tetR/pTet to activate a gene of interest in presence of C8-CAI-1. The gene of interest is <I>als</I> that encodes for the acetolactate synthase (Als). This enzyme synthetized diacetyl from pyruvate<SUP><A href="http://www.kegg.jp/kegg-bin/highlight_pathway?scale=1.0&amp;map=vhr00650&amp;keyword=diacetyl" target="_blank">3</A></SUP>. Diacetyl is our ransmitter molecule (Figure 1).
      </P><P>
       The pBBR1MCS-4<SUP><A href="http://www.kegg.jp/kegg-bin/highlight_pathway?scale=1.0&amp;map=vhr00650&amp;keyword=diacetyl" target="_blank">4</A></SUP>, a broad host range plasmid, was chosen to allow the transfer of the system into <I>V. harveyi</I> by conjugation (i.e. this is the only way to modify the <I>V. harveyi</I> chassis). 
      </P><P>
In conclusion, we designed a <I>V. harveyi</I> strain enable to detect both exogenous CAI-1 or C8-CAI-1, and to produce diacetyl as a molecular response.
  </P></SECTION><SECTION class="modules_design" style="border:solid 5px #f37b6f;margin-top:0px;margin-bottom: 20px;"><H2 style="color:#f37b6f;"><I>P. pastoris</I></H2><P><I>V. harveyi</I> cannot not be used as the effector since production of antimicrobial peptides (AMPs) is lethal for <I> Vibrio </I> species. <I>P. pastoris</I> is a yeast commonly used in academic laboratories and industry for its high potential to produce protein. In addition, yeasts were previously described to produce a wide range of AMPs <SUP><A href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494115/
" target="_blank">5</A>,<A href="https://www.ncbi.nlm.nih.gov/pubmed/23624708" target="_blank">6</A></SUP>. Finally, a system allowing efficient communication between yeast and prokaryotes has already been decribed i.e. the diacetyl-dependant Odr-10 receptor system<SUP><A href="https://2013.igem.org/Team:SCUT" target="_blank">7</A></SUP>. This system allows the expression of targets genes under the control of pFUS1 via the Ste12 pathway (Figure 2). For all these reason, we thus chose <I>P. pastoris</I>. We used the constitutive pGAP promoter to express the receptor Odr-10 in <I>P. pastoris</I></P><P>
To kill<I> V. cholerae</I>, we looked for a new and innovative antibiotic solution to limit the risk of acquired-resistance. We decided to use AMPs, that are small membrane disrupting molecules toxic for a large panel of microorganisms<SUP><A href="https://www.ncbi.nlm.nih.gov/pubmed/27837316" target="_blank">8</A></SUP>. Here we selected AMPs from crocodiles. Crocodiles live in harsh environment and are known to possess an impressive defence system, that allows them to catch very few disease and antimicrobial peptides are part of it<SUP><A href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490821/" target="_blank">9</A></SUP>. We focused on 3 different AMPs described to have the best efficiency against <I>V. cholerae</I>. Those AMPs are Leucrocin I<SUP><A href="http://www.sciencedirect.com/science/article/pii/S0145305X10003071?via%3Dihub" target="_blank">10</A></SUP>, D-NY15<SUP><A href="https://www.ncbi.nlm.nih.gov/pubmed/24192554" target="_blank">11</A></SUP> and cOT2<SUP><A href="http://www.sciencedirect.com/science/article/pii/S0005273617300433" target="_blank">12</A></SUP>. Leucrocine I possess one cationic charge for 7 amino acids. D-NY15 is its optimized counterpart with 4 cationic charges and a sequence of 15 amino-acid long. Finally, cOT2 is 29 amino acid long and possesses 6 cationic charges. These AMPs were placed under control of the pGAP constitutive promoter for preliminary tests and under pFUS1 promoter to promote their expression in response to diacetyl. The genetic constructions were inserted into the  integrative pPICZα plasmid i.e. a good plasmid for protein production. The signal peptide α-factor was fused to the AMPs to allow for secretion of the peptides.
</P><P>
The action of these AMPs is the last event of our synthetic consortium.
</P></SECTION></DIV><SECTION style="padding-left:20%;"><H1 style="text-align: left;">Experimental plan</H1><H2><I>E. coli</I></H2><P>
        Quorum sensing molecule production
      </P><UL><LI>Measurement of C8-CAI-1 &amp; CAI-1in supernateant by NMR</LI><LI>Bioluminescence assay</LI></UL></SECTION><SECTION style="padding-left:20%;"><H2><I>V. harveyi</I></H2><P>
        Conjugation
      </P><UL><LI> Conjugation test using a plasmid expressing RFP</LI></UL><P>
        Diacetyl production
      </P><UL><LI> Measurement by NMR of diacetyl in supernateant of <I> E. coli</I> and <I>V. harveyi</I> producing strains </LI></UL></SECTION><SECTION style="padding-left:20%;"><H2><I>P. pastoris</I></H2><P>
           Diacetyl detection
      </P><UL><LI><I> In vivo </I> functionality of pGAP using RFP reporter system </LI><LI><I> In vivo </I> functionality of ODR10/pFUS1 system  test using RFP reporter system </LI></UL><P>
        Antimicrobial peptides (AMPs)
      </P><UL><LI>Verification of AMP genes expression by RT-PCR</LI><LI>Verification of AMPs activity by toxicity assay</LI></UL></SECTION><SECTION class="links_end"><TABLE><TBODY><TR><TH colspan="3">
            Strategy pages
          </TH></TR><TR><TD><A href="https://2017.igem.org/Team:INSA-UPS_France/Description">Description</A></TD><TD><I>Design</I></TD><TD><A href="https://2017.igem.org/Team:INSA-UPS_France/Parts">Parts</A></TD></TR></TBODY></TABLE></SECTION></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>